Mammoth
Developing in vivo gene editing therapeutics to transform patient lives.
An early MBC BioLabs resident, they began with 5 people and left with 20 as they outgrew the space. The company has since expanded to 90+ employees, raised over $200M and announced partnerships with four major pharma companies.